• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: VIAL; LUBRICANT, PATIENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

VIAL; LUBRICANT, PATIENT Back to Search Results
Device Problem Device Markings/Labelling Problem (2911)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Description
In xxxxx of 2022, a finding was reported by an administrator of the family birth center here at xxxxxxx medical center of xxxxxxxx, xxxxxxxxx.The potential medication error that was involved is the "muri-lube" mineral oil 2ml vials, which are not for parenteral use.These vials are quite similar in appearance in regards to shape and size to injectable vials of diphenhydramine, hydralazine, fentanyl, atropine and more.Although the color of the safety dust caps are distinguishable, it is not enough to mitigate the risk of its improper use.The appearance of these vials could have easily been mistaken for iv fentanyl or lidocaine and possibly been intravenously administered.Swiftly, a meeting was held with the leaders of the hospital from the departments of pharmacy, anesthesia, supply chain, and quality assurance.The in patient pharmacy and anesthesia departments identified all locations of fiberoptic carts i the medical center and performed a sweep to remove all the vials and replace them with a more distinguishable product, 30ml mineral oil cups manufactured by mckesson.Furthermore, a flyer titled "practice alert: mineral oil fiber optics cart" was created to elucidate the look-alike-sound-alike (lasa) risk that was posed by the previous formulation and placed throughout anesthesia units, family birth centers, and throughout other units that utilize mineral oil.This finding, when communicated wit other xxxxxxxxxxx medical facilities, received much recognition in mitigating risk and ensuring patient safety.(b)(4).
 
Event Description
Additional information received for report mw511207 on 11/8/2022 to update procode.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VIAL
Type of Device
LUBRICANT, PATIENT
MDR Report Key15428502
MDR Text Key300233964
Report NumberMW5112070
Device Sequence Number1
Product Code KMJ
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 11/08/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received09/14/2022
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received11/08/2022
Patient Sequence Number1
Treatment
MURI-LUBE/OIL/VIAL/10ML
-
-